Ambrisentan for the treatment of pulmonary arterial hypertension

por Casserly, Brian, Klinger, James R
Publicado 2009

Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent

por Casserly, Brian, Klinger, James R
Publicado 2009

Mesenchymal Stromal Cell Extracellular Vesicles: A New Approach for Preventing Bronchopulmonary Dysplasia?

por Klinger, James R., Matthay, Michael A.
Publicado 2022

Diagnosis and Management of Pulmonary Arterial Hypertension

por Houtchens, Jeanne, Martin, Douglas, Klinger, James R.
Publicado 2011

Light at the ENDothelium-role of Sox17 and Runx1 in endothelial dysfunction and pulmonary arterial hypertension

por Simmons Beck, Robert, Liang, Olin D., Klinger, James R.
Publicado 2023

Partial anomalous pulmonary venous return presenting with adult-onset pulmonary hypertension

por Sears, Edmund H., Aliotta, Jason M., Klinger, James R.
Publicado 2012

Riociguat: Clinical research and evolving role in therapy

por Klinger, James R., Chakinala, Murali M., Langleben, David, Rosenkranz, Stephan, Sitbon, Olivier
Publicado 2020

Deletion of the Npr3 gene increases severity of acute lung injury in obese mice

por Guarino, Brianna D., Dado, Christopher D., Kumar, Ashok, Braza, Julie, Harrington, Elizabeth O., Klinger, James R.
Publicado 2023

Effect of dose, dosing intervals, and hypoxic stress on the reversal of pulmonary hypertension by mesenchymal stem cell extracellular vesicles

por Klinger, James R, Pereira, Mandy, Tatto, Michael Del, Dooner, Mark S, Wen, Sicheng, Quesenberry, Peter J, Liang, Olin D
Publicado 2021

The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension

por Banerjee, Debasree, Kamuren, Jane, Baird, Grayson L., Palmisciano, Amy, Krishnan, Ipsita, Whittenhall, Mary, Klinger, James R., Ventetuolo, Corey E.
Publicado 2017

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

por Humbert, Marc, Guignabert, Christophe, Bonnet, Sébastien, Dorfmüller, Peter, Klinger, James R., Nicolls, Mark R., Olschewski, Andrea J., Pullamsetti, Soni S., Schermuly, Ralph T., Stenmark, Kurt R., Rabinovitch, Marlene
Publicado 2019

Low dose 100 cGy irradiation as a potential therapy for pulmonary hypertension

por Egan, Pamela C., Liang, Olin D., Goldberg, Laura R., Aliotta, Jason M., Pereira, Mandy, Borgovan, Theodor, Dooner, Mark, Camussi, Giovanni, Klinger, James R., Quesenberry, Peter J.
Publicado 2019

Prevalence and risk factors of pulmonary hypertension among adult patients with HIV infection in Ethiopia

por Huluka, Dawit Kebede, Mekonnen, Desalew, Abebe, Sintayehu, Meshesha, Amha, Mekonnen, Dufera, Deyessa, Negussie, Klinger, James R., Ventetuolo, Corey E., Schluger, Neil W., Sherman, Charles B., Amogne, Wondwossen
Publicado 2020

Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model

por Aliotta, Jason M., Pereira, Mandy, Wen, Sicheng, Dooner, Mark S., Del Tatto, Michael, Papa, Elaine, Cheng, Yan, Goldberg, Laura, Ventetuolo, Corey E., Liang, Olin, Klinger, James R., Quesenberry, Peter J.
Publicado 2017

Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trial

por Walsh, Thomas P., Baird, Grayson L., Atalay, Michael K., Agarwal, Saurabh, Arcuri, Daniel, Klinger, James R., Mullin, Christopher J., Morreo, Heather, Normandin, Brynn, Shiva, Sruti, Whittenhall, Mary, Ventetuolo, Corey E.
Publicado 2021

Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database

por Ventetuolo, Corey E., Hess, Edward, Austin, Eric D., Barón, Anna E., Klinger, James R., Lahm, Tim, Maddox, Thomas M., Plomondon, Mary E., Thompson, Lauren, Zamanian, Roham T., Choudhary, Gaurav, Maron, Bradley A.
Publicado 2017

Reply to Helgeson et al.: Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?

por LaPatra, Tess, Baird, Grayson L., Goodman, Randi, Pinder, Diane, Gaffney, Maeve, Klinger, James R., Palevsky, Harold I., Fritz, Jason, Mullin, Christopher J., Mazurek, Jeremy A., Kawut, Steven M., Ventetuolo, Corey E.
Publicado 2022

Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension

por Jeong, Euy-Myoung, Pereira, Mandy, So, Eui-Young, Wu, Keith Q, Del Tatto, Michael, Wen, Sicheng, Dooner, Mark S, Dubielecka, Patrycja M, Reginato, Anthony M, Ventetuolo, Corey E, Quesenberry, Peter J, Klinger, James R, Liang, Olin D
Publicado 2022

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors

por Hoeper, Marius M., Simonneau, Gérald, Corris, Paul A., Ghofrani, Hossein-Ardeschir, Klinger, James R., Langleben, David, Naeije, Robert, Jansa, Pavel, Rosenkranz, Stephan, Scelsi, Laura, Grünig, Ekkehard, Vizza, Carmine Dario, Chang, MiKyung, Colorado, Pablo, Meier, Christian, Busse, Dennis, Benza, Raymond L.
Publicado 2017

SOX17 enhancer variants disrupt transcription factor binding and enhancer inactivity drives pulmonary hypertension

por Walters, Rachel, Vasilaki, Eleni, Aman, Jurjan, Chen, Chien-Nien, Wu, Yukyee, Liang, Olin D, Ashek, Ali, Dubois, Olivier, Zhao, Lin, Sabrin, Farah, Cebola, Inês, Ferrer, Jorge, Morrell, Nicholas W, Klinger, James R, Wilkins, Martin R, Zhao, Lan, Rhodes, Christopher J
Publicado 2023